TITLE

Conserved anchorless surface proteins as group A streptococcal vaccine candidates

AUTHOR(S)
Henningham, Anna; Chiarot, Emiliano; Gillen, Christine; Cole, Jason; Rohde, Manfred; Fulde, Marcus; Ramachandran, Vidiya; Cork, Amanda; Hartas, Jon; Magor, Graham; Djordjevic, Steven; Cordwell, Stuart; Kobe, Bostjan; Sriprakash, Kabada; Nizet, Victor; Chhatwal, G.; Margarit, Immaculada; Batzloff, Michael; Walker, Mark
PUB. DATE
October 2012
SOURCE
Journal of Molecular Medicine;Oct2012, Vol. 90 Issue 10, p1197
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Streptococcus pyogenes (group A Streptococcus (GAS)) causes ∼700 million human infections each year, resulting in over 500,000 deaths. The development of a commercial GAS vaccine is hampered by the occurrence of many unique GAS serotypes, antigenic variation within the same serotype, differences in serotype geographical distribution, and the production of antibodies cross-reactive with human tissue that may lead to autoimmune disease. Several independent studies have documented a number of GAS cell wall-associated or secreted metabolic enzymes that contain neither N-terminal leader sequences nor C-terminal cell wall anchors. Here, we applied a proteomic analysis of serotype M1T1 GAS cell wall extracts for the purpose of vaccine development. This approach catalogued several anchorless proteins and identified two protective vaccine candidates, arginine deiminase and trigger factor. These surface-exposed enzymes are expressed across multiple GAS serotypes exhibiting ≥99% amino acid sequence identity. Vaccine safety concerns are alleviated by the observation that these vaccine candidates lack human homologs, while sera from human populations suffering repeated GAS infections and high levels of autoimmune complications do not recognize these enzymes. Our study demonstrates anchorless cell surface antigens as promising vaccine candidates for the prevention of GAS disease.
ACCESSION #
79824467

 

Related Articles

  • Reevaluating the Concept of Treating Experimental Tumors with a Mixed Bacterial Vaccine: Coley's Toxin. Maletzki, C.; Klier, U.; Obst, W.; Kreikemeyer, B.; Linnebacher, M. // Clinical & Developmental Immunology;2012, p1 

    Several decades after Coley's initial work, we here systematically analyzed tumoricidal as well as immunostimulatory effects of the historical preparation Coley's Toxin (CT), a safe vaccine made of heat-inactivated S. pyogenes and S. marcescens. First, by performing in vitro analysis,...

  • Protective Immune Response against Streptococcus pyogenes in Mice after Intranasal Vaccination with the Fibronectin-Binding Protein SfbI. Guzman, Carlos A.; Talay, Susanne R.; Molinari, Gabriella; Medina, Eva; Chhatwal, Gursharan S. // Journal of Infectious Diseases;4/1/99, Vol. 179 Issue 4 

    Examines the protective immune response against Streptococcus pyogenes in mice after the intranasal vaccination with fibronectin-binding protein SfbI. Characterization of S. pyogenes; Role of fibronectin-binding proteins of S. pyogenes in bacterial attachment; Construction and purification of...

  • Study of T Serotypes and Emm Genotypes of Streptococcus pyogenes in Children with Pharyngitis and Tonsillitis. Okabe, Toshinari; Takeda, Sachiyo; Hida, Masatoshi; Narisada, Tomomi // Journal of Nippon Medical School;2011, Vol. 78 Issue 3, p174 

    Streptococcus pyogenes, or group A Streptococcus (GAS), causes superficial infections of the upper respiratory tract that manifest as diseases such as pharyngitis and tonsillitis. T serotypes, emm genotypes, and the antimicrobial susceptibility of GAS isolated from the pharynges of patients with...

  • Epidemiological Typing of Streptococcus Pyogenes Strains Isolated from Patients with Acute Tonsillopharyngitis. PETKOVA, Tanja; PACHKOVA, Svetlana; DECHEVA, Antoaneta; KANEV, Kalin; BOGDANOV, Nikolay; POPIVANOV, Ivan // Balkan Military Medical Review;2011, Vol. 14 Issue 3, p212 

    The use of epidemiological typing method allows for the differentiation of individual strains of group A streptococci (GAS, Streptococcus pyogenes) of different origin. This method is important in determining the genetic relationships between microorganisms in organized groups as teaching...

  • Growth phase-associated changes in the transcriptome and proteome of Streptococcus pyogenes. Chaussee, Michelle A.; Dmitriev, Alexander V.; Callegari, Eduardo A.; Chaussee, Michael S. // Archives of Microbiology;Jan2008, Vol. 189 Issue 1, p27 

    Streptococcus pyogenes is responsible for approximately 500,000 deaths each year worldwide. Many of the associated virulence factors are expressed in a growth phase-dependent manner. To identify growth phase-associated changes in expression on a genomescale, the exponential and stationary phase...

  • Internalization-Associated Proteins among Streptococcus pyogenes Isolated from Asymptomatic Carriers and Children with Pharyngitis. Musumeci, R.; Lo Bue, C.; Milazzo, I; Nicoletti, G; Serra, A.; Speciale, A.; Blandino, G. // Clinical Infectious Diseases;7/15/2003, Vol. 37 Issue 2, p173 

    Sixty-two strains of Streptococcus pyogenes isolated from 30 asymptomatic school children and 32 children with pharyngitis were characterized to analyze the involvement of 2 fibronectin-binding proteins (F/SfbI and PrtF2/PfbpI) in S. pyogenes colonizing asymptomatic carriers and to determine the...

  • In Brief.  // Nature Reviews Microbiology;Oct2006, Vol. 4 Issue 10, p724 

    The article reports developments related to microbiology. The secretion of two Streptococcus pyogenes proteins that are known to have different localization patterns, the M protein localizes to the septum whereas PrtF localizes to the old poles of growing cells was examined. Natural killer T...

  • Group A Streptococcus tissue invasion by CD44-mediated cell signaling. Cywes, Colette; Wessels, Michael R. // Nature;12/6/2001, Vol. 414 Issue 6864, p648 

    Studies the hyaluronic acid-binding protein CD44-mediated interaction of group A Streptococcus (GAS) with human keratinocytes. GAS-induced disruption of intercellular junctions; GAS translocation across model epithelia.

  • Targeted Curing of All Lysogenic Bacteriophage from Streptococcus pyogenes Using a Novel Counter-selection Technique. Euler, Chad W.; Juncosa, Barbara; Ryan, Patricia A.; Deutsch, Douglas R.; McShan, W. Michael; Fischetti, Vincent A. // PLoS ONE;1/12/2016, Vol. 11 Issue 1, p1 

    Streptococcus pyogenes is a human commensal and a bacterial pathogen responsible for a wide variety of human diseases differing in symptoms, severity, and tissue tropism. The completed genome sequences of >37 strains of S. pyogenes, representing diverse disease-causing serotypes, have been...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics